Antioxidant, selenium and risk of nonalcoholic fatty liver disease, more than causality.
暂无分享,去创建一个
Fang Wang | X. Bai | Zhengye Liu | J. Mi
[1] G. Lv,et al. Genetic factors in the clinical predictive model for hepatocellular carcinoma: Evidence from genetic association analyses. , 2023, Journal of hepatology.
[2] G. Lv,et al. Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study , 2022, Hepatology International.
[3] X. Bai,et al. Identification of blood metabolites linked to the risk of cholelithiasis: a comprehensive Mendelian randomization study , 2022, Hepatology International.
[4] V. Zuber,et al. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches , 2022, American journal of human genetics.
[5] K. Clément,et al. Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515). , 2021, Journal of hepatology.